Search hospitals
>
California
>
Davis
Sutter Davis Hospital
Claim this profile
Davis, California 95616
Global Leader in Lung Cancer
Global Leader in Breast Cancer
Conducts research for Breast cancer
Conducts research for Non-Small Cell Lung Cancer
Conducts research for Ovarian Cancer
96 reported clinical trials
7 medical researchers
Summary
Sutter Davis Hospital is a medical facility located in Davis, California. This center is recognized for care of Lung Cancer, Breast Cancer, Breast cancer, Non-Small Cell Lung Cancer, Ovarian Cancer and other specialties. Sutter Davis Hospital is involved with conducting 96 clinical trials across 240 conditions. There are 7 research doctors associated with this hospital, such as Ari Baron, MD, Deepti Behl, Kristie A. Bobolis, and Jorge A. Garcia-Young.
Area of expertise
Lung Cancer
Sutter Davis Hospital has run 21 trials for Lung Cancer. Some of their research focus areas include:
Breast Cancer
Sutter Davis Hospital has run 19 trials for Breast Cancer. Some of their research focus areas include:
Top PIs
Ari Baron, MD
Alta Bates Summit Medical Center-Herrick Campus
9 years of reported clinical research
Deepti Behl
California Pacific Medical Center-Pacific Campus
5 years of reported clinical research
Kristie A. Bobolis
Sutter Medical Center Sacramento
2 years of reported clinical research
Jorge A. Garcia-Young
Sutter Solano Medical Center/Cancer Center
10 years of reported clinical research
Clinical Trials running at Sutter Davis Hospital
Ovarian Cancer
Esophageal cancer
Lung Cancer
Breast Cancer
Kidney Cancer
Multiple Myeloma
Breast cancer
Non-Small Cell Lung Cancer
Esophageal Adenocarcinoma
Gastric cancer
Olaparib +/- Bevacizumab
for Ovarian Cancer
This phase III trial compares the effect of olaparib for one year versus two years, with or without bevacizumab, for the treatment of BRCA 1/2 mutated or homologous recombination deficient stage III or IV ovarian cancer. Olaparib is a polyadenosine 5'-diphosphoribose polymerase (PARP) enzyme inhibitor and may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Bevacizumab is in a class of medications called antiangiogenic agents. It works by stopping the formation of blood vessels that bring oxygen and nutrients to tumor. This may slow the growth and spread of tumor. Giving olaparib for one year with or without bevacizumab may be effective in treating patients with BRCA 1/2 mutated or homologous recombination deficient stage III or IV ovarian cancer, when compared to two years of olaparib.
Recruiting
2 awards
Phase 3
4 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Sutter Davis Hospital?
Sutter Davis Hospital is a medical facility located in Davis, California. This center is recognized for care of Lung Cancer, Breast Cancer, Breast cancer, Non-Small Cell Lung Cancer, Ovarian Cancer and other specialties. Sutter Davis Hospital is involved with conducting 96 clinical trials across 240 conditions. There are 7 research doctors associated with this hospital, such as Ari Baron, MD, Deepti Behl, Kristie A. Bobolis, and Jorge A. Garcia-Young.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.